PCOS Challenge to Host Major Patient-Focused Drug Development Meeting for Polycystic Ovary Syndrome

WASHINGTON, Sept. 18, 2023 /PRNewswire/ — Despite affecting up to 15% of women and a $15 billion annual economic burden in the U.S. alone, polycystic ovary syndrome (PCOS) has yet to see any treatments specifically for the disorder approved by the U.S. Food and Drug Administration (FDA)….